{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:45:35Z","timestamp":1782719135907,"version":"3.54.5"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04886-w","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:47:47Z","timestamp":1777704467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medicine price and affordability in China and selected ASEAN countries: a cross-country comparison with forward-looking implications for regional pooled procurement"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhuangqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"key":"4886_CR1","unstructured":"World Health Organization. The Second Workshop of the public procurement agencies in the South-East Asia Region on improving access to medicines. 2024. https:\/\/www.who.int\/publications\/i\/item\/sea-hsd-406. Accessed 14 July 2025."},{"key":"4886_CR2","unstructured":"World Health Organization. The World Medicines Situation. 2024. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/0e7a37ba-2131-4473-b265-6237730c1f42\/content. Accessed 26 June 2025."},{"key":"4886_CR3","unstructured":"Organization for Economic Co-operation and Development. Drug spending in OECD countries up by nearly a third since 1998, according to new OECD data. 2005. https:\/\/one.oecd.org\/document\/PAC\/COM\/NEWS(2005)21\/en\/pdf. Accessed 14 July 2025."},{"key":"4886_CR4","unstructured":"World Health Organization. Equitable access to essential medicines: a framework for collective action. 2004. https:\/\/iris.who.int\/items\/d05c5ec4-6af6-4b78-99e9-062f97bf1115. Accessed 20 July 2025."},{"issue":"9659","key":"4886_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(08)61762-6","volume":"373","author":"A Cameron","year":"2009","unstructured":"Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009;373(9659):240\u20139.","journal-title":"Lancet"},{"key":"4886_CR6","unstructured":"Association of Southeast Asian Nations. ASEAN Statistical yearbook 2023. Vol. 19. 2023. https:\/\/www.aseanstats.org\/wp-content\/uploads\/2023\/12\/ASYB-2023-v1.pdf. Accessed 20 July 2025."},{"key":"4886_CR7","unstructured":"World Health Organization. Thirty-first world health assembly. 1978. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/86043\/Official_record247_eng.pdf?sequence=1&isAllowed=y. Accessed 6 August 2025."},{"key":"4886_CR8","unstructured":"World Health Organization. Workshop of the public procurement agencies in the WHO South-East Asia Region on improving access to medicines. 2023. https:\/\/www.who.int\/southeastasia\/internal-publications-detail\/workshop-of-the-public-procurement-agencies-in-the-who-south-east-asia-region-on-improving-access-to-medicines. Accessed 11 August 2025."},{"key":"4886_CR9","doi-asserted-by":"publisher","first-page":"e000243","DOI":"10.1136\/bmjgh-2016-000243","volume":"2","author":"G Seidman","year":"2017","unstructured":"Seidman G, Atun R. Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries. BMJ Glob Health. 2017;2:e000243.","journal-title":"BMJ Glob Health"},{"issue":"9","key":"4886_CR10","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.socscimed.2012.05.044","volume":"75","author":"M Huff-Rousselle","year":"2012","unstructured":"Huff-Rousselle M. The logical underpinnings and benefits of pooled pharmaceutical procurement: a pragmatic role for our public institutions? Soc Sci Med. 2012;75(9):1572\u201380.","journal-title":"Soc Sci Med"},{"issue":"1","key":"4886_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12992-023-00974-1","volume":"19","author":"K Parmaksiz","year":"2023","unstructured":"Parmaksiz K, van de Bovenkamp H, Bal R. Does structural form matter? A comparative analysis of pooled procurement mechanisms for health commodities. Global Health. 2023;19(1):90.","journal-title":"Global Health"},{"issue":"10","key":"4886_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2471\/BLT.21.285761","volume":"99","author":"S Vogler","year":"2021","unstructured":"Vogler S, Haasis MA, van den Ham R, Humbert T, Garner S, Suleman F. European collaborations on medicine and vaccine procurement. Bull World Health Organ. 2021;99(10):715\u201321.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"4886_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12992-022-00847-z","volume":"18","author":"K Parmaksiz","year":"2022","unstructured":"Parmaksiz K, Pisani E, Bal R, Kok MO. A systematic review of pooled procurement of medicines and vaccines: identifying elements of success. Global Health. 2022;18(1):59.","journal-title":"Global Health"},{"key":"4886_CR14","unstructured":"Mendoza OM. Regional pooled procurement of essential medicines in the Western Pacific Region: An asset or a liability? The University of Auckland: Centre for Development Studies. 2010. https:\/\/cdn.auckland.ac.nz\/assets\/arts\/Departments\/development-studies\/documents\/working-paper-series\/O\u2019neal%20Menoza%20WPS%201_20102.pdf. Accessed 8 October 2025."},{"key":"4886_CR15","unstructured":"Organization for Economic Co-operation and Development. Health at a Glance: Asia\/Pacific 2024. 2024. https:\/\/www.oecd.org\/en\/publications\/health-at-a-glance-asia-pacific-2024_51fed7e9-en\/full-report\/component-42.html#chapter-d1e19392-8102fe7a77. Accessed 10 October 2025."},{"issue":"11","key":"4886_CR16","doi-asserted-by":"publisher","first-page":"e007724","DOI":"10.1136\/bmjgh-2021-007724","volume":"7","author":"DTV La","year":"2022","unstructured":"La DTV, Zhao Y, Arokiasamy P, Atun R, Mercer S, Marthias T, et al. Multimorbidity and out-of-pocket expenditure for medicines in China and India. BMJ Glob Health. 2022;7(11):e007724.","journal-title":"BMJ Glob Health"},{"key":"4886_CR17","unstructured":"The State Council (The People\u2019s Republic of China). China\u2019s first cross-border pharmaceutical regional collection platform officially launched. 2025. https:\/\/www.gov.cn\/yaowen\/liebiao\/202501\/content_6997587.htm. Accessed 12 August 2025."},{"key":"4886_CR18","unstructured":"China Daily. Nation deepens ASEAN health ties. 2025. https:\/\/www.chinadaily.com.cn\/a\/202501\/24\/WS6792ec18a310a2ab06ea90fd.html. Accessed 15 August 2025."},{"issue":"1","key":"4886_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1470-2045(15)00449-0","volume":"17","author":"S Vogler","year":"2016","unstructured":"Vogler S, Vitry A, Babar ZU. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study. Lancet Oncol. 2016;17(1):39\u201347.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4886_CR20","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S2214-109X(24)00442-X","volume":"13","author":"L Oldfield","year":"2025","unstructured":"Oldfield L, Penm J, Mirzaei A, Moles R. Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis. Lancet Glob Health. 2025;13(1):e50\u20138.","journal-title":"Lancet Glob Health"},{"key":"4886_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2261-10-25","volume":"10","author":"MS van Mourik","year":"2010","unstructured":"van Mourik MS, Cameron A, Ewen M, Laing RO. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO\/HAI data. BMC Cardiovasc Disord. 2010;10:25.","journal-title":"BMC Cardiovasc Disord"},{"key":"4886_CR22","unstructured":"Association of Southeast Asian Nations Main Portal. ASEAN Socio-Cultural Community Policy Brief. 2024. https:\/\/asean.org\/wp-content\/uploads\/2024\/04\/ASCC-RD_Policy-Brief_Health5-2024.pdf. Accessed 13 August 2025."},{"issue":"10417","key":"4886_CR23","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/S0140-6736(23)02691-0","volume":"402","author":"The Lancet","year":"2023","unstructured":"The Lancet. Non-communicable diseases in China: a rising tide. Lancet. 2023;402(10417):2045.","journal-title":"Lancet"},{"key":"4886_CR24","unstructured":"Shanghai Sunshine Medical Procurement All-in-One. National Volume-Based Procurement. https:\/\/www.smpaa.cn\/gjsdcg\/index.shtml(2025)."},{"key":"4886_CR25","unstructured":"Drug and Medical Supply Information Center of the Ministry of Public Health. Regular Purchase Reference Price. https:\/\/dmsic.moph.go.th\/index\/drugsearch\/1(2025)."},{"key":"4886_CR26","unstructured":"e-catalogue. Indonesia. Government Goods\/Services Procurement Policy Institute (LKPP). https:\/\/e-katalog.lkpp.go.id\/(2025)."},{"key":"4886_CR27","unstructured":"The Department of Health (The Philippines). Drug Price Reference Index (DPRI). https:\/\/pharma.doh.gov.ph\/drug-price-reference-index\/(2025)."},{"key":"4886_CR28","unstructured":"Office Portal of Pharmaceutical Services Programme. Ministry of Health Malaysia. Malaysia Medicines Price Guide. https:\/\/pharmacy.moh.gov.my\/en\/apps\/drug-price(2025)."},{"key":"4886_CR29","unstructured":"International Labor Organization (ILO). Statistics on wages. https:\/\/ilostat.ilo.org\/topics\/wages\/(2025)."},{"key":"4886_CR30","unstructured":"World Health Organization. Measuring medicine prices, availability, affordability and price components, 2nd edition. 2008. https:\/\/www.who.int\/publications\/i\/item\/WHO-PSM-PAR-2008.3. Accessed 8 April 2025."},{"key":"4886_CR31","unstructured":"Management Sciences for Health (MSH). International Medical Products Price Guide. (2015 Edition). https:\/\/msh.org\/wp-content\/uploads\/2020\/03\/msh-2015-international-medical-products-price-guide.pdf(2015)."},{"issue":"1","key":"4886_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40258-021-00670-4","volume":"20","author":"D Moye-Holz","year":"2022","unstructured":"Moye-Holz D, Vogler S. Comparison of Prices and Affordability of Cancer Medicines in 16 Countries in Europe and Latin America. Appl Health Econ Health Policy. 2022;20(1):67\u201377.","journal-title":"Appl Health Econ Health Policy"},{"issue":"8","key":"4886_CR33","doi-asserted-by":"publisher","first-page":"e252043","DOI":"10.1001\/jamahealthforum.2025.2043","volume":"6","author":"OJ Wouters","year":"2025","unstructured":"Wouters OJ, Denolle C, Wei J, Papanicolas I. Prices and Affordability of Essential Medicines in 72 Low-, Middle-, and High-Income Markets. JAMA Health Forum. 2025;6(8):e252043.","journal-title":"JAMA Health Forum"},{"key":"4886_CR34","unstructured":"Teo H, Sin. Medicines regulatory systems and scope for regulatory harmonization in Southeast Asia (English). Washington, D.C.: World Bank Group. http:\/\/documents.worldbank.org\/curated\/en\/727671496171008743"},{"issue":"5","key":"4886_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s40258-019-00480-9","volume":"17","author":"SL Wong","year":"2019","unstructured":"Wong SL, Ibrahim S, Abdul Kadir N, Mohd Salleh S. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy. Appl Health Econ Health Policy. 2019;17(5):641\u201354.","journal-title":"Appl Health Econ Health Policy"},{"key":"4886_CR36","unstructured":"World Health Organization. Pricing policy guideline to improve affordable access to medicines. 2020. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/92f7b2d6-633b-4ac7-bf86-c0bf4d584ad2\/content. Accessed 14 August 2025."},{"key":"4886_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1744-8603-10-34","volume":"10","author":"M Hinsch","year":"2014","unstructured":"Hinsch M, Kaddar M, Schmitt S. Enhancing medicine price transparency through price information mechanisms. Global Health. 2014;10:34.","journal-title":"Global Health"},{"key":"4886_CR38","doi-asserted-by":"publisher","first-page":"1362374","DOI":"10.3389\/fphar.2024.1362374","volume":"15","author":"J Gao","year":"2024","unstructured":"Gao J, Liu C, Li Y, Chen X, Xue T, Tang Y. Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China. Front Pharmacol. 2024;15:1362374.","journal-title":"Front Pharmacol"},{"key":"4886_CR39","doi-asserted-by":"publisher","first-page":"e00552","DOI":"10.1002\/prp2.552","volume":"7","author":"AV Perez","year":"2019","unstructured":"Perez AV, Trujillo AJ, Mejia AE, Contreras JD, Sharfstein JM. Evaluating the centralized purchasing policy for the treatment of hepatitis C: the Colombian CASE. Pharmacol Res Perspect. 2019;7:e00552.","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"4886_CR40","doi-asserted-by":"publisher","first-page":"2390653","DOI":"10.1080\/20523211.2024.2390653","volume":"17","author":"K Parmaksiz","year":"2024","unstructured":"Parmaksiz K, Asingizwe D, Gichohi AK, Karengera S. Towards regional access to medicines: the development of the East African Community pooled procurement mechanism. J Pharm Policy Pract. 2024;17(1):2390653.","journal-title":"J Pharm Policy Pract"},{"key":"4886_CR41","unstructured":"Europe Union. Study on best practices in the public procurement of medicines: final report. 2022. https:\/\/data.europa.eu\/doi\/10.2925\/044781. Accessed 17 September 2025."},{"key":"4886_CR42","unstructured":"World Health Organization. Regional Office for Europe. Cross-country collaborations to improve access to medicines and vaccines in the WHO European Region. 2020. https:\/\/iris.who.int\/handle\/10665\/332933. Accessed 15 September."},{"key":"4886_CR43","doi-asserted-by":"publisher","first-page":"101649","DOI":"10.1016\/j.cegh.2024.101649","volume":"28","author":"AV Katherine Feng","year":"2024","unstructured":"Katherine Feng AV, Miranda JC, Obnial ID, Ebhodaghe DE, Lucero-Prisno III. Drug regulatory harmonization in the Association of Southeast Asian Nations: Is it time for an ASEAN medicines agency? A policy review. Clin Epidemiol Glob Health. 2024;28:101649.","journal-title":"Clin Epidemiol Glob Health"},{"issue":"1","key":"4886_CR44","first-page":"13","volume":"7","author":"J Ghangas","year":"2019","unstructured":"Ghangas J, Jain N, Sinha A. A critical view of harmonization of regulatory requirements for Generic Drug approval submissions in ASEAN countries. Int J Drug Regul Affairs. 2019;7(1):13\u201324.","journal-title":"Int J Drug Regul Affairs"},{"key":"4886_CR45","unstructured":"World Health Organization. List of National Regulatory Authorities (NRAs) operating at maturity level 3 (ML3) and maturity level 4 (ML4). 2025. https:\/\/www.who.int\/publications\/m\/item\/list-of-nras-operating-at-ml3-and-ml4. Accessed 7 October."},{"key":"4886_CR46","unstructured":"Singapore Health Sciences Authority. HSA Singapore the First National Regulatory Authority Awarded the Highest Recognition for an Advanced Medicines Regulatory System by the World Health Organization. 2022. https:\/\/www.hsa.gov.sg\/announcements\/press-release\/who-ml4. Accessed 11 May 2025."},{"issue":"8","key":"4886_CR47","doi-asserted-by":"publisher","first-page":"e009798","DOI":"10.1136\/bmjgh-2022-009798","volume":"7","author":"M Xu","year":"2022","unstructured":"Xu M, Zhang L, Feng X, Zhang Z, Huang Y. Regulatory reliance for convergence and harmonisation in the medical device space in Asia-Pacific. BMJ Glob Health. 2022;7(8):e009798.","journal-title":"BMJ Glob Health"},{"issue":"1","key":"4886_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/hpm.822","volume":"21","author":"D DeRoeck","year":"2006","unstructured":"DeRoeck D, Bawazir SA, Carrasco P, Kaddar M, Brooks A, Fitzsimmons J, Andrus J. Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program. Int J Health Plann Manage. 2006;21(1):23\u201343.","journal-title":"Int J Health Plann Manage"},{"key":"4886_CR49","volume-title":"Lawrence. Countering the Problem of Falsified and Substandard Drugs","author":"JB Gillian","year":"2013","unstructured":"Gillian JB. and O. G. Lawrence. Countering the Problem of Falsified and Substandard Drugs. Washington, DC: National Academies; 2013."},{"key":"4886_CR50","unstructured":"Association of Southeast Asian Nations Main Portal. Situational Analysis and Feasibility of Regional Collaboration to Improve ASEAN Drug Security and Self-Reliance (ADSSR). 2022. https:\/\/asean.org\/wp-content\/uploads\/2023\/01\/2-Situational-Analysis-and-Feasibility-of-Regional-Collaboration-to-Improve-ASEAN-Drug-Security-and-Self-Reliance-ADSSR-EPUB-28-Dec-2022.pdf. Accessed 17 September 2025."},{"issue":"4","key":"4886_CR51","doi-asserted-by":"publisher","first-page":"103655","DOI":"10.1016\/j.euroecorev.2021.103655","volume":"132","author":"P Dubois","year":"2021","unstructured":"Dubois P, Lefouili Y, Straub S. Pooled Procurement of Drugs in Low-and-Middle Income Countries. Eur Econ Rev. 2021;132(4):103655.","journal-title":"Eur Econ Rev"},{"issue":"3suppl","key":"4886_CR52","first-page":"79","volume":"19","author":"DJ Ripin","year":"2013","unstructured":"Ripin DJ, Jamieson D, Meyers A, Warty U, Dain M, Khamsi C. Antiretroviral Procurement and Supply Chain Management. Antivir Ther. 2013;19(3suppl):79\u201389.","journal-title":"Antivir Ther"},{"key":"4886_CR53","doi-asserted-by":"publisher","first-page":"693426","DOI":"10.3389\/fphar.2021.693426","volume":"12","author":"S Shukar","year":"2021","unstructured":"Shukar S, Zahoor F, Hayat K, Saeed A, Gillani AH, Omer S, et al. Drug Shortage: Causes, Impact, and Mitigation Strategies. Front Pharmacol. 2021;12:693426.","journal-title":"Front Pharmacol"},{"key":"4886_CR54","unstructured":"Nemzoff C, Chalkidou K, Over M. Aggregating demand for pharmaceuticals is appealing, but pooling is not a panacea. Center for Global Development. 2019. https:\/\/www.cgdev.org\/sites\/default\/files\/aggregating-demand-pharmaceuticals-appealing-pooling-not-panacea.pdf. Accessed 15 September 2025."},{"issue":"1","key":"4886_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1017\/S1744133116000219","volume":"12","author":"N Azzopardi-Muscat","year":"2017","unstructured":"Azzopardi-Muscat N, Schroder-B\u00e4ck P, Brand H. The European Union Joint Procurement Agreement for cross-border health threats: what is the potential for this new mechanism of health system collaboration? Health Econ Policy Law. 2017;12(1):43\u201359.","journal-title":"Health Econ Policy Law"},{"key":"4886_CR56","unstructured":"Syam N. Regional Pooled Procurement of Medicines in the East African Community. South Centre. 2014; Report No.: 53. 2014. https:\/\/www.southcentre.int\/wp-content\/uploads\/2014\/09\/RP53_Regional-Pooled-Procurement-of-Medicines-in-EAC_ENRev.pdf. Accessed 16 September 2025."},{"issue":"1","key":"4886_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12992-016-0208-2","volume":"12","author":"A Pezzola","year":"2016","unstructured":"Pezzola A, Sweet CM. Global pharmaceutical regulation: the challenge of integration for developing states. Global Health. 2016;12(1):85.","journal-title":"Global Health"},{"key":"4886_CR58","doi-asserted-by":"crossref","unstructured":"Lezotre PL. Value and Influencing Factors of the Cooperation, Convergence, and Harmonization in the Pharmaceutical Sector. Int Cooperation Convergence Harmonization Pharm Regulations. San Diego: Academic Press; 2014.","DOI":"10.1016\/B978-0-12-800053-3.00003-3"},{"key":"4886_CR59","unstructured":"Association of Southeast Asian Nations Main Portal. Regional Collaborative Strategy for ASEAN Drug Security and Self-Reliance. 2020. https:\/\/theaseanmagazine.asean.org\/article\/regional-collaborative-strategy-for-asean-drug-security-and-self-reliance\/. Accessed 25 September 2025."},{"key":"4886_CR60","unstructured":"Lexology. Presidential Regulation No. 10 of 2021 on Investment Business Activity: The Major Changes in the Indonesia\u2019s Investment Climate. 2021. https:\/\/www.lexology.com\/library\/detail.aspx?g=81765ac0-6f25-4ef7-96b9-266f53ddc0dd. Accessed 13 July 2025."},{"key":"4886_CR61","unstructured":"Geneve network. Localisation barriers to trade in the biopharmaceutical industry. 2023. https:\/\/geneva-network.com\/research\/localisation-barriers-to-trade-in-the-biopharmaceutical-industry\/. Accessed 20 July 2025."},{"key":"4886_CR62","unstructured":"Pharmaceutical Research and Manufacturers of America (PhRMA). Separating fact from fiction -how localization barriers fail where positive non-discriminatory incentives succeed. a global assessment of Localization policies and incentivizing Life Science investment and innovation. 2016. https:\/\/www.pugatch-consilium.com\/reports\/Localization%20Paper_US_FINAL.pdf. Accessed 23 September 2025."},{"issue":"1","key":"4886_CR63","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/s12913-020-05362-8","volume":"20","author":"NM Hamzah","year":"2020","unstructured":"Hamzah NM, Perera PN, Rannan-Eliya RP. How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014. BMC Health Serv Res. 2020;20(1):509.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"4886_CR64","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tips.2015.06.006","volume":"36","author":"M Nor Norazmi","year":"2015","unstructured":"Nor Norazmi M, Lim LS. Halal pharmaceutical industry: opportunities and challenges. Trends Pharmacol Sci. 2015;36(8):496\u20137.","journal-title":"Trends Pharmacol Sci"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04886-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:02:24Z","timestamp":1782716544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04886-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4886"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04886-w","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"367"}}